Skip to main content

Table 6 Markers for T, NK and B-cells and Neutrophils.

From: Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model

   

Slc26a4 +/+

Slc26a4 -/-

  

No.

Gene

Description

Intensity

P

Intensity

P

Fold

Direction

1

Tcra

T-cell receptor, alpha

214

0/9

190

0/9

  

2

Tcrb-V13

T-cell receptor, beta V13

136

4/36

109

4/36

  

3

Tcrb-J

T-cell receptor, beta V13

71

2/15

50

1/15

  

4

Tcrg

T-cell receptor, gamma V4

54

0/15

43

0/15

  

5

Cd3d

Cd3 antigen

10

0/3

8

0/3

  

6

Cd3e

Cd3 antigen

139

0/6

74

0/6

  

7

Cd3g

Cd3 antigen

43

0/3

28

0/3

  

8

Cd3z

Cd3 antigen

182

4/24

139

3/24

  

9

Cd4

Cd4 antigen

20

0/6

149

0/6

  

10

Cd8a

Cd8 antigen

144

4/15

143

4/15

  

11

Cd8b

Cd8 antigen

1,313

3/6

1,343

3/6

  

12

Ncam1

Cd56

562

8/21

654

12/21

1.16

 

13

Fcgr3

IgG receptor, low aff, Cd16

162

2/3

401

3/3

2.48

up

14

Sdc1

Syndecan 1 (Cd138)

77

3/12

72

3/12

  

15

Cd19

Cd19 antigen

15

0/3

13

0/3

  

16

Mpo

Myeloperoxidase

159

0/3

73

0/3

  

17

Defb1

Beta-defensin 1

66

1/6

72

2/6

  

18

Defb2

Beta-defensin 2

23

0/3

14

0/3

  

19

Defb3

Beta-defensin 3

31

0/3

70

0/3

  

20

Defb4

Beta-defensin 4

85

0/3

63

0/3

  

21

Camp

Cathelicidin

11

0/3

10

0/3

  
  1. Genes that can serve as markers for T-cells (1–11), NK-cells (12–13), B-cells (14–15) and neutrophils (16–21) are listed. For parameters 'P', 'Fold' and 'Direction', see the Gene array section in Methods. Fold changes are given when a gene was called Present (P) in Slc26a4 +/- or Slc26a4 -/- samples in at least half of the available probes. The direction of the fold change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not considered significant.